Please try another search
For the nine months ended 30 September 2021, InspireMD Inc revenues increased 34% to $3.1M. Net loss increased 62% to $10.8M. Revenues reflect CGuard segment increase from $1.1M to $3M, Italy segment increase of 57% to $677K, Other segment increase of 19% to $1.2M. Higher net loss reflects Research and development increase from $1.5M to $3.6M (expense), General and administrative (including increase of 32% to $5.5M (expense).
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 1.07 | 1.04 | 1.01 | 0.16 |
Gross Profit | 0.09 | 0.26 | 0.11 | -0.39 |
Operating Income | -4.03 | -3.44 | -3.31 | -3.72 |
Net Income | -4.07 | -3.51 | -3.24 | -3.85 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 42.61 | 46.38 | 48.63 | 17.78 |
Total Liabilities | 5.54 | 5.54 | 4.68 | 5.61 |
Total Equity | 37.06 | 40.83 | 43.95 | 12.16 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -10.31 | -6.17 | -3.64 | -9.08 |
Cash From Investing Activities | -24.3 | -0.11 | -0.02 | -0.19 |
Cash From Financing Activities | 35.03 | 35.07 | 35.07 | 16.39 |
Net Change in Cash | 0.41 | 28.77 | 31.39 | 7.13 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review